Len Neckers Selected Research

Prostatic Neoplasms (Prostate Cancer)

1/2022	Selective vulnerabilities in the proteostasis network of castration-resistant prostate cancer.
11/2013	Synthesis and structure-activity relationship studies of novel dihydropyridones as androgen receptor modulators.
3/2012	Methoxychalcone inhibitors of androgen receptor translocation and function.
10/2008	Inhibition of Hsp90 activates osteoclast c-Src signaling and promotes growth of prostate carcinoma cells in bone.
10/2007	Intratumor injection of the Hsp90 inhibitor 17AAG decreases tumor growth and induces apoptosis in a prostate cancer xenograft model.
3/2006	Curcumin is an inhibitor of p300 histone acetylatransferase.
9/2005	Hsp90 inhibitors identified from a library of novobiocin analogues.
5/2002	Heat shock protein 90 inhibition by 17-allylamino-17- demethoxygeldanamycin: a novel therapeutic approach for treating hormone-refractory prostate cancer.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Len Neckers Research Topics

Disease

83	Neoplasms (Cancer) 11/2023 - 01/2002
12	Hypoxia (Hypoxemia) 01/2022 - 01/2002
11	Carcinogenesis 01/2023 - 11/2003
10	Neoplasm Metastasis (Metastasis) 01/2016 - 11/2003
9	Kidney Neoplasms (Kidney Cancer) 12/2014 - 09/2004
8	Prostatic Neoplasms (Prostate Cancer) 01/2022 - 05/2002
7	Renal Cell Carcinoma (Grawitz Tumor) 12/2019 - 09/2004
7	Breast Neoplasms (Breast Cancer) 07/2018 - 01/2002
5	Leiomyomatosis 12/2019 - 01/2007
4	Urinary Bladder Neoplasms (Bladder Cancer) 01/2017 - 01/2011
3	Neurodegenerative Diseases (Neurodegenerative Disease) 01/2018 - 04/2007
3	Lung Neoplasms (Lung Cancer) 01/2017 - 04/2002
3	Disease Progression 01/2010 - 01/2007
3	Mast-Cell Leukemia (Leukemia, Mast Cell) 05/2008 - 02/2004
3	Necrosis 10/2007 - 03/2003
3	Inflammation (Inflammations) 10/2007 - 03/2003
2	Alzheimer Disease (Alzheimer's Disease) 01/2018 - 04/2007
2	Carcinoma (Carcinomatosis) 01/2017 - 10/2008
2	Hereditary leiomyomatosis and renal cell cancer 08/2009 - 02/2007
2	Mast Cell Activation Disorders (Mast-Cell Disease) 05/2008 - 04/2004
2	Colitis 04/2006 - 09/2005
2	Acute Myeloid Leukemia (Acute Myelogenous Leukemia) 10/2005 - 02/2004
2	Mastocytosis 04/2004 - 02/2004
1	Mucositis 12/2020
1	Diarrhea 12/2020
1	Fatigue 12/2020
1	Vomiting 12/2020
1	Nausea 12/2020
1	Neurofibromatosis 1 (Neurofibromatosis Type I) 01/2019
1	Bacterial Infections (Bacterial Infection) 01/2018
1	Chronic Disease (Chronic Diseases) 01/2018
1	Osteosarcoma (Osteogenic Sarcoma) 10/2016
1	Sarcoma (Soft Tissue Sarcoma) 10/2016

Drug/Important Bio-Agent (IBA)

40	Proteins (Proteins, Gene)FDA Link 01/2023 - 01/2002
34	Heat-Shock Proteins (Heat-Shock Protein)IBA 01/2019 - 01/2002
28	Molecular Chaperones (Chaperone, Molecular)IBA 02/2016 - 01/2002
12	Phosphotransferases (Kinase)IBA 09/2015 - 05/2002
8	Oncogene Proteins (Oncogene Protein)IBA 01/2016 - 04/2002
8	geldanamycinIBA 01/2013 - 05/2002
8	tanespimycin (17AAG)IBA 01/2013 - 02/2003
7	Fumarate Hydratase (Fumarase)IBA 12/2019 - 08/2005
6	EnzymesIBA 12/2019 - 02/2007
5	Tyrosine Kinase InhibitorsIBA 06/2022 - 05/2002
5	Oxygen (Dioxygen)IBA 01/2022 - 04/2004
4	Tyrosine (L-Tyrosine)FDA Link 08/2015 - 05/2002
4	Transcription Factors (Transcription Factor)IBA 01/2012 - 01/2002
4	Receptor Protein-Tyrosine Kinases (Tyrosine Kinase Receptors)IBA 01/2007 - 01/2002
3	(2,4- dihydroxy- 5- isopropylphenyl)- (5- (4- methylpiperazin- 1- ylmethyl)- 1,3- dihydroisoindol- 2- yl)methanoneIBA 12/2020 - 08/2015
3	Histones (Histone)IBA 01/2017 - 04/2002
3	STA 9090IBA 01/2017 - 01/2013
3	Reactive Oxygen Species (Oxygen Radicals)IBA 03/2015 - 08/2009
3	Glucose (Dextrose)FDA LinkGeneric 08/2014 - 08/2009
3	Protein-Tyrosine Kinases (Tyrosine Kinase)IBA 10/2012 - 09/2008
2	SNX 2112IBA 06/2022 - 01/2017
2	Mitogen-Activated Protein Kinase Kinases (MEKs)IBA 06/2022 - 01/2019
2	HSP70 Heat-Shock Proteins (Heat-Shock Protein 70)IBA 01/2022 - 07/2018
2	Biomarkers (Surrogate Marker)IBA 12/2020 - 01/2017
2	NucleotidesIBA 07/2018 - 05/2002
2	Dasatinib (BMS 354825)FDA Link 02/2018 - 10/2008
2	ProteomeIBA 01/2017 - 09/2011
2	Protein Kinases (Protein Kinase)IBA 09/2015 - 09/2008
2	FumaratesIBA 12/2014 - 08/2005
2	Insulin (Novolin)FDA Link 02/2013 - 07/2006
2	Hormones (Hormone)IBA 01/2013 - 05/2002
2	beta CateninIBA 01/2013 - 05/2008
2	Cisplatin (Platino)FDA LinkGeneric 08/2012 - 10/2010
2	Androgen Receptors (Androgen Receptor)IBA 03/2012 - 11/2003
2	Bortezomib (Velcade)FDA Link 10/2010 - 05/2004
2	UbiquitinIBA 01/2010 - 09/2004
2	Gefitinib (Iressa)FDA Link 09/2008 - 11/2003
2	Histone Deacetylase InhibitorsIBA 03/2006 - 04/2002
2	Imatinib Mesylate (Gleevec)FDA Link 10/2005 - 04/2004
2	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 09/2005 - 03/2003
2	Anti-Bacterial Agents (Antibiotics)IBA 02/2005 - 02/2004
2	ErbB Receptors (EGF Receptor)IBA 09/2004 - 05/2002
2	Rifabutin (Ansamycin)FDA Link 02/2004 - 02/2003
1	4- (2,6- dichlorobenzoylamino)- 1H- pyrazole- 3- carboxylic acid piperidin-4-ylamideIBA 12/2020
1	Proteasome Endopeptidase Complex (Proteasome)IBA 12/2019
1	DNA (Deoxyribonucleic Acid)IBA 01/2019
1	AMP-Activated Protein KinasesIBA 01/2019
1	TOR Serine-Threonine KinasesIBA 01/2019
1	Positive Transcriptional Elongation Factor BIBA 01/2019
1	benzothiazoleIBA 07/2018
1	5- (2,4- dihydroxy- 5- isopropylphenyl)- 4- (4- morpholin- 4- ylmethylphenyl)isoxazole- 3- carboxylic acid ethylamideIBA 01/2017
1	CUDC 305IBA 01/2017
1	STA-12-8666IBA 10/2016
1	Topoisomerase I InhibitorsIBA 10/2016
1	Irinotecan (Camptosar)FDA LinkGeneric 10/2016
1	Indicators and Reagents (Reagents)IBA 02/2016
1	Adenosine Triphosphatases (ATPase)IBA 01/2016
1	Endoplasmic Reticulum Chaperone BiPIBA 01/2016
1	Complement System Proteins (Complement)IBA 09/2015
1	LipidsIBA 03/2015
1	Glutamine (L-Glutamine)FDA Link 03/2015
1	GlucocorticoidsIBA 02/2014

Therapy/Procedure

18	Therapeutics 11/2023 - 05/2002
2	Drug Therapy (Chemotherapy) 03/2015 - 08/2012
2	Cystectomy 12/2011 - 01/2011
2	Urinary Diversion (Ileal Conduit) 12/2011 - 01/2011
1	Castration 01/2022